Phase 2 Liver Cancer Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have a confirmed diagnosis of hepatocellular carcinoma (a type of liver cancer)
• People whose largest liver tumour is bigger than 7 cm
• People who have a tumour clot present in the main vein leading to the liver (as seen on medical imaging)
• People whose liver cancer has come back after a previous surgery to remove the tumour, or after a procedure to destroy it
• People who are generally well enough to carry out light activity and care for themselves (as measured by a standard health performance scale)
• People whose liver is functioning at a level classified as Child-Pugh class A or B (a measure of liver health — confirm with trial site)
• People whose blood counts and organ function meet specific minimum levels, including white blood cells, platelets, haemoglobin, liver enzymes, kidney function, and blood clotting time (confirm exact values with trial site)
• People with a life expectancy of at least 3 months

Who may not be able to join:

• People who have a tumour clot extending into the large vein that carries blood back to the heart
• People whose cancer has spread to the brain or nervous system
• People who have already received certain liver-directed or systemic treatments, including TACE, HAIC, TAE, radiotherapy, or systemic cancer therapy
• People whose heart or kidneys are not functioning well enough to tolerate the treatments used in this trial
• People who have a history of another type of cancer
• People with an infection that cannot be controlled
• People with a history of HIV
• People who have previously had an organ or cell transplant

Important: Always verify eligibility with the trial site directly before applying.